LACTO-N-FUCOPENTAOSE III

LACTO-N-FUCOPENTAOSE III Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

solid

Verwenden

Lacto-N-fucopentaose III (Cas# 25541-09-7) is a human milk oilgosaccharide. It can inhibit the adherence of pathogens to the intestinal epithelium.

LACTO-N-FUCOPENTAOSE III Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

LACTO-N-FUCOPENTAOSE III Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19552	58
Aladdin Scientific		tp@aladdinsci.com	United States	52923	58
Shanghai Beiwanta Biotechnology Co., Ltd.	021-67187366 19901745723	info@bwtlab.com	China	9654	58
Tianjin Aiyuxuan Pharmaceutical Technology?Co.,Ltd	13312134804	mark_zhang@yuxuanpharm.com	China	380	58
J & K SCIENTIFIC LTD.	18210857532; 18210857532	jkinfo@jkchemical.com	China	96815	76
Hunan Hui Bai Shi Biotechnology Co., Ltd.	0731-85526065 13308475853	ivy@hnhbsj.com	China	7247	62
Hangzhou Dingyan Chem Co., LTD	0571-87157530-8008 17369838938	sales@dingyanchem.com	China	2386	58
Shanghai YuanYe Biotechnology Co., Ltd.	021-61312847; 18021002903	3008007409@qq.com	China	71826	60
Chengdu Push Bio-Technology Co., Ltd.	028-028-85370565-229-229 18080489829	18080489829@163.com	China	8248	60
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226 +86-13028896684;	sales@rrkchem.com	China	57422	58

---

• GAL-BETA1,4(FUC-ALPHA1,3)GLCNAC-BETA1,3GAL-BETA1,4GLC
• LEWIS-X PENTASACCHARIDE
• LEWIS-X-PENTASACCHARIDE-GEL
• LEX
• LE(X)-LACTOSE
• LEX-PENTASACCHARIDE
• LACTO-N-FUCOPENTAOSE III
• LACTO-N-FUCOPENTAOSE III-GEL
• LACTO-N-FUCOPENTAOSE III, HUMAN MILK
• III3FUC-NLCOSE4
• BETA-D-GAL-[1->4]-(ALPHA-L-FUC-[1->3])-BETA-D-GLCNAC-[1->3]-BETA-D-GAL-[1->4]-D-GLC
• LNF III
• LNF III-GEL
• LNFP III
• Lacto-N-fucopentaose Ⅲ
• lacto-N-fucopentaose iii*from human milk
• β-d-gal-(1→4)-[α-l-fuc-(1→3)]-β-d-glcnac-(1→3)-β-d-gal-(1→4)-d-glc
• N-[2-[3,5-dihydroxy-2-(hydroxymethyl)-6-(1,2,4,5-tetrahydroxy-6-oxohexan-3-yl)oxyoxan-4-yl]oxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl]acetamide
• Lex-lactose, Lewis-X pentasaccharide, LNFP III, β-D-Gal-(1-4)-[α-L-Fuc-(1-3)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc
• Lacto-N-fucopentaose III ,95%
• D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-
• Lewis X antigen
• Galβ1,4(Fucα1,3)GlcNAcβ1,3Galβ1,4Glc
• Gal-b-1,4-(Fuc-a-1,3)-GlcNAc-b-1,3-D-Gal-b-1,4-Glc
• CD15 ANTIGEN
• 3-FAL
• ELFT
• FUTIV
• Lewis X (Lex)
• 25541-09-7
• C32H55NO25H2O
• BioChemical
• Carbohydrate Analysis
• Carbohydrate Standards
• Proteomics
• Proteomics and Protein Expression
• Post-translational Modification